Tazeen Ahmad

Stock Analyst at B of A Securities

(1.49)
# 1676
Out of 5,370 analysts
240
Total ratings
40.34%
Success rate
5.62%
Average return
55 Stocks
Name Action PT Current % Upside Ratings Updated
SRPT Sarepta Therapeutics
Downgrades: Neutral
76 28
20.99 33.4% 22 Jun 16, 2025
ASND Ascendis Pharma
Maintains: Strong Buy
201 216
177.69 21.56% 10 Jun 9, 2025
ACAD ACADIA Pharmaceutica...
Maintains: Neutral
18 23
22.12 3.98% 14 Jun 5, 2025
PRTA Prothena Corp
Downgrades: Underperform
22 4
5.71 -29.95% 6 May 28, 2025
STRO Sutro Biopharma
Maintains: Underperform
1 1
0.87 -8.05% 3 May 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
28 27
14.59 85.06% 3 May 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
41 23
18.32 25.55% 7 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
55 68
51.79 31.3% 15 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
63 68
62.34 9.08% 8 Apr 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
302 325
308.78 5.25% 3 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
54 28
7.38 279.4% 2 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
73 70
53.25 31.46% 5 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
42 40
4.38 813.24% 4 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
184 179
125.3 42.86% 3 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
13.04 68.71% 1 Dec 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
6 3
1.48 102.7% 3 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
68 90
71.13 26.53% 5 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 15
6.05 147.93% 5 Oct 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
11 6
9.06 -33.77% 14 Oct 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
125 150
106.15 41.31% 7 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
10 2
6.79 -70.54% 6 Sep 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
535 607
551.73 10.02% 3 Jun 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
83 76
37.03 105.24% 6 May 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
16 14
3.98 251.76% 2 Apr 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
7 10
2.43 311.52% 4 Mar 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
2 6
1.23 387.8% 2 Mar 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
8.78 70.84% 1 Feb 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
3
n/a n/a 2 Jan 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
7 1
n/a n/a 1 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
8 11
16.62 -33.81% 3 Dec 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
36 31
n/a n/a 2 Aug 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
10
10.27 -2.63% 6 Jul 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
7 2
3.35 -40.3% 2 Apr 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
2 7
n/a n/a 3 Feb 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
90 20
n/a n/a 2 Dec 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
6
0.97 518.56% 4 Nov 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
75 15
9.79 53.22% 3 Nov 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
390 60
43.77 37.08% 2 Jun 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
23
n/a n/a 2 May 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
16
1.21 1222.31% 1 Nov 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 2 Oct 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
24 20
n/a n/a 2 Mar 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
13 5
n/a n/a 1 Mar 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
43
10.03 328.71% 2 Sep 25, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
45 47
n/a n/a 2 Aug 3, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
6
n/a n/a 4 Apr 9, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
233 227
n/a n/a 4 Feb 26, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 3 Sep 30, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 4 Apr 25, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
330 300
9.44 3077.97% 1 Nov 2, 2018